Clinical Trials Directory

Trials / Completed

CompletedNCT03398317

Sperm Selection by Either PICSI or MACS in Cases With Abnormal Sperm DNA Fragmentation Index for ICSI

PICSI vs. MACS for Abnormal Sperm DNA Fragmentation ICSI Cases: a Prospective Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
396 (actual)
Sponsor
Ganin Fertility Center · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

On the day of ICSI, choosing the best sperm by either PICSI or magnetic activated cell sorting (MACS) in cases with abnormal DNA is not fully investigated. This study helps in solving this problem by using two known techniques to achieve that purpose.

Detailed description

Sperm DNA fragmentation has shown a negative correlation with fertilization rate, embryo quality, and implantation rate. And a positive correlation with miscarriage rate in the 1st trimester. Sperm selection methods like PICSI and MACS have been developed for selecting a healthy mature non apoptotic sperm with healthy membrane for Oocyte injection so as to obtain best embryo quality and achieve higher ongoing pregnancy rates. A sperm selection technique based on sperm membrane binding to hyaluronic acid (PICSI Dish), the main substrate of the oocyte zonapellucida, could improve the likelihood of obtaining better sperm for ICSI with non fragmented DNA. Another sperm selection technique based on Magnetic activated cell sorting (MACS) that depends on the binding of protein Annexin V to phosphatidylserine which is a marker for apoptosis, giving a resulting (eluted) spermatozoa without DNA fragmentation. In order to determine which sperm selection technique is better for dealing with DNA fragmentation patients we need to study both techniques on two different groups of patients

Conditions

Interventions

TypeNameDescription
OTHERPICSIsperm selection using PICSI dish for selecting sperm with lower DNA fragmentation index
OTHERMACSsperm selection using MACS for selecting sperm with lower DNA fragmentation index

Timeline

Start date
2017-01-01
Primary completion
2019-03-30
Completion
2019-03-30
First posted
2018-01-12
Last updated
2020-07-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03398317. Inclusion in this directory is not an endorsement.